GLP-1 medications are everywhere right now, but finding the right provider to prescribe and support you on them can make all the difference. In this episode, Dr. Sarah Stombaugh breaks down what you should look for when choosing a clinician for medications like Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda.
You’ll learn why these medications, originally developed for type 2 diabetes, are now used for many other conditions, including obesity, cardiovascular risk reduction, metabolic liver disease, and even sleep apnea. With more specialists prescribing them than ever before, the key question isn’t who prescribes them, it’s whether they can truly support you through the process.
Dr. Stombaugh explains the biggest green flags and RED flags to watch for, including why regular follow-ups, dose adjustments, and accessible communication with your care team are essential for both safety and long-term success. She also shares why it’s important that you consider how well a clinic helps with prior authorizations and cost-savings options.
You’ll also hear why many people struggle on these medications. Often people struggle not because the treatment is wrong for them, but because they weren’t given the guidance or support they needed.
If you’ve had a difficult experience with GLP-1 medications before, or you’re considering starting them, this episode will help you understand what good care should actually look like.
Ready to get started on your weight loss journey? We’re now enrolling patients for in-person visits in Charlottesville, Virginia, and for telemedicine throughout the states of Illinois, Tennessee, and Virginia. Learn more and get started today at https://www.sarahstombaughmd.com
If you’re looking for support during your GLP journey, check out The GLP Guide. This on-demand video program will give you answers to the questions you have! Get started today at https://www.sarahstombaughmd.com/glp
Disclaimer: This podcast is for educational purposes only and is not medical advice. Always talk with your personal physician.